- Design
- Case report with toxicological analysis
- Population
- One adult man after ingestion of a concentrated kratom alkaloid product
- Primary outcome
- Cause of death and alkaloid concentrations
- Effect
- About 87 mg 7-hydroxymitragynine ingested; findings consistent with opioid-like toxidrome
A case report in Annals of Emergency Medicine, published on 27 October 2026, describes a man in his forties found dead at home after reportedly taking three tablets of a commercial product sold as 7-hydroxymitragynine, a kratom alkaloid, with several beers. Post-mortem findings included froth at the mouth and nose, severe pulmonary oedema and a distended bladder, with no trauma or injection use.
Analysis of a remaining tablet found 29 mg of 7-hydroxymitragynine and a smaller amount of mitragynine pseudoindoxyl, an even more potent opioid agonist. The authors estimate the total ingestion was 19 to 87 times the 7-hydroxymitragynine exposure from a high dose of dried leaf. Other drugs, including gabapentin, were at subtherapeutic levels.
Kratom has moved from leaf preparations to purified and chemically enriched products sold under the same name. These behave far more like potent opioids than the traditional plant, and standard urine drug screens do not detect them.
- Ask specifically about kratom and '7-OH' products in suspected opioid toxicity with a negative drug screen.
- Treat respiratory depression with suspected kratom exposure as opioid toxicity, including naloxone.
- Watch for co-ingestion with alcohol or gabapentinoids, which add respiratory depression.
- Report suspected cases to poison centres or pharmacovigilance services.
Why it matters
Products sold as kratom now include concentrated opioid agonists that standard screens miss.
Don't overread it
A single post-mortem case report — it cannot establish how often these products cause death.
The statistics, in plain English
This is one case. The 19- to 87-fold figure is an estimate comparing the measured tablet content with typical leaf doses, not a measured population risk.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free